Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
504studies shown
Showing 201-225 of 504
RecruitingNCT06672588

Magnetic Seizure Therapy for Schizophrenia - Trial

This study is looking at whether Magnetic Seizure Therapy (MST) can help people with Treatment Resistant Schizophrenia, Schizophrenia, or schizoaffective disorder. Participants take part in Magnetic Seizure Therapy (MST) and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT07383324

Heat Stress in Individuals With Schizophrenia

This study is looking at care and outcomes for people with Heat Stress, Physiological Stress, or Cognitive Change. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 85 Years
Countries
Canada
Sponsor
University of Ottawa
Condition
Schizophrenia
Active Not RecruitingNCT04338152

Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial

This study is looking at whether problem-solving support can help people with psychosis, Prodromal Symptoms, Prodromal Schizophrenia, or Family. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 13 Years to 25 Years
Countries
Canada, United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
Active Not RecruitingNCT06251193

Optimizing CBSST With Executive Function Training for Schizophrenia

This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia or schizoaffective disorder. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

SchizophreniaOtherOver 60 Years
Countries
Canada, United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
RecruitingNCT05435300

Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia

This study is looking at examine changes in synaptic density with transcranial direct current stimulation (tDCS) in the brains of patients with schizophrenia for people with Schizophrenia or Schizoaffective. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT05731414

Outcomes From Remediation and Behavioural Intervention Techniques

This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia or Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Toronto
Condition
Schizophrenia
Not Yet RecruitingNCT07122531

Recovery With Exogenous Ketones and Antipsychotics

This study is looking at assess changes in circulating ketone levels and metabolic markers (glucose, insulin, HbA1c) for people with First Episode Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Université de Sherbrooke
Condition
Schizophrenia
RecruitingNCT07056894

Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis

This study is looking at whether treatment with ABCR helps patients with EPP reduce their alcohol and/or cannabis use for people with Psychosis, Alcohol Use Disorder, or Cannabis Use Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 16 Years to 30 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Schizophrenia
RecruitingNCT07001878

Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis

This observational study is following people with Psychosis or Cannabis Use to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherFrom 18 Years to 25 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Schizophrenia
RecruitingNCT06126224

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Belgium, Canada, Chile, China, Greece, Hungary, Mexico, Peru, Poland, South Korea, Switzerland, Turkey, United Kingdom, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT05980949

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czech Republic, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Mexico, Peru, Poland, Portugal, United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, Ukraine, United Kingdom
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT06373484

Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents

This study is looking at whether cognitive behavioural therapy can help people with Disruptive Behavior Disorder, Emotional Disorder, Behavioural Disorder, or Attention Deficit Hyperactivity Disorder. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

ADHDOtherFrom 6 Years to 12 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
ADHD
Active Not RecruitingNCT05279313

A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.

This study is looking at whether Centanafadine Hydrochloride can help people with Attention Deficit/Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

ADHDOtherFrom 4 Years to 18 Years
Countries
Canada, United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
RecruitingNCT06221358

Pharmacogenomics of Stimulant Treatment Response

This observational study is following people with Attention-Deficit/ Hyperactivity Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

ADHDOtherFrom 6 Years to 24 Years
Countries
Canada
Sponsor
University of Calgary
Condition
ADHD
RecruitingNCT05916339

AWARE: Management of ADHD in Autism Spectrum Disorder

This study is looking at whether a digital support tool can help people with Adhd or Autism Spectrum Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

ADHDOtherFrom 4 Years to 17 Years
Countries
Canada, United States
Sponsor
Daniel Coury
Condition
ADHD
RecruitingNCT04278404

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

This observational study is following people with Coronavirus Infection, Pulmonary Arterial Hypertension, Urinary Tract Infections in Children, or Hypertension to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

ADHDOtherFrom 0 Years to 20 Years
Countries
Canada, United States
Sponsor
Duke University
Condition
ADHD
RecruitingNCT05997680

A Parent-child Yoga Intervention for Reducing Attention Deficits in Children with Congenital Heart Disease: a Feasibility Study

This study is looking at whether a digital support tool can help people with Congenital Heart Disease, Child Development, Neurodevelopmental Disorders, or Parents. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

ADHDOtherFrom 4 Years to 6 Years
Countries
Canada
Sponsor
Anne Gallagher
Condition
ADHD
RecruitingISRCTN90111395

Are antidepressants more effective than placebo, when given in combination with mood stabilisers, in preventing mood episodes in people with Bipolarity type I?

This study is looking at whether Open label acute treatment phase: 1 can help people with Bipolarity type I depression, Mental and Behavioural Disorders, or Bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

BipolarityOtherOver 18 Years
Countries
Canada
Sponsor
University of British Columbia (Canada)
Condition
Bipolarity
RecruitingISRCTN36852818

Psychoeducation versus cognitive-behavioral therapy in bipolarity

This study is looking at whether cognitive behavioural therapy can help people with bipolarity or Mental and Behavioural Disorders. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

BipolarityOtherOver 18 Years
Countries
Canada
Sponsor
University of Toronto (Canada)
Condition
Bipolarity